Interestingly, Gathungu et al. 69 demonstrated that elevated GM-CSF autoantibody was a risk marker for aggressive Crohn’s disease behavior and complications including surgery, indicating that deficiency of GM-CSF can contribute to a relative immunodeficiency. This evidence concerns the gene CSF2 and immune system disorder.